当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:211.44亿  总市值:211.44亿
流通股本:28.04亿   总股本:28.04亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金13,052,263,813.386,535,506,477.8526,284,830,929.5220,017,362,283.17
  收到的税费返还297,353,645.61148,716,993.34564,637,199.44437,089,373.63
  收到其他与经营活动有关的现金152,411,464.5535,537,858.65314,266,906.41259,273,351.77
  经营活动现金流入小计13,502,028,923.546,719,761,329.8427,163,735,035.3720,713,725,008.57
  购买商品、接受劳务支付的现金11,282,077,575.216,918,296,320.5619,183,664,918.4413,161,667,283.29
  支付给职工以及为职工支付的现金1,036,586,807.14506,769,238.421,888,800,255.381,386,666,122.25
  支付的各项税费313,267,323.28122,889,775.631,064,967,949.58838,239,192.44
  支付其他与经营活动有关的现金480,957,133.89327,363,483.781,017,042,265.74615,992,412.25
  经营活动现金流出小计13,112,888,839.527,875,318,818.3923,154,475,389.1416,002,565,010.23
  经营活动产生的现金流量净额389,140,084.02-1,155,557,488.554,009,259,646.234,711,159,998.34
二、投资活动产生的现金流量:
  收回投资收到的现金83,631,190.33240,191,771.749,416,904.1124,295,712.51
  取得投资收益收到的现金29,819,638.7416,232,473.0889,022,905.5142,580,649.61
  处置固定资产、无形资产和其他长期资产收回的现金净额11,498,534.54927,536.213,929,974.232,152,974.23
  处置子公司及其他营业单位收到的现金净额322,188,026.4---
  投资活动现金流入小计447,137,390.01257,351,780.99142,369,783.8569,029,336.35
  购建固定资产、无形资产和其他长期资产支付的现金1,134,643,863.42522,609,583.682,085,097,608.711,523,816,613.12
  投资支付的现金1,084,758,939.83261,022,618.051,021,970,127.421,915,477,856.39
  取得子公司及其他营业单位支付的现金--154,418,006.87200,613,641.06
  支付其他与投资活动有关的现金2,883,915.81624,339.925,064,758.893,803,296.41
  投资活动现金流出小计2,222,286,719.06784,256,541.633,286,550,501.893,643,711,406.98
  投资活动产生的现金流量净额-1,775,149,329.05-526,904,760.64-3,144,180,718.04-3,574,682,070.63
三、筹资活动产生的现金流量:
  取得借款收到的现金1,983,278,909.211,040,647,9955,303,483,203.634,197,857,434.78
  收到其他与筹资活动有关的现金277,489,110.71216,991,590.33631,857,578.29546,103,814.09
  筹资活动现金流入小计2,260,768,019.921,257,639,585.335,935,340,781.924,743,961,248.87
  偿还债务支付的现金1,876,810,000.01957,100,0005,009,880,000.023,928,170,000.01
  分配股利、利润或偿付利息支付的现金25,564,775.5313,136,936.451,255,746,825.791,242,864,719.66
  支付其他与筹资活动有关的现金335,766,648.9190,391,605.65677,245,874.35614,073,851.66
  筹资活动现金流出小计2,238,141,424.441,160,628,542.16,942,872,700.165,785,108,571.33
  筹资活动产生的现金流量净额22,626,595.4897,011,043.23-1,007,531,918.24-1,041,147,322.46
四、汇率变动对现金及现金等价物的影响-61,143,692.42-31,457,118.4317,029,234.725,528,099.8
五、现金及现金等价物净增加额-1,424,526,341.97-1,616,908,324.39-125,423,755.35120,858,705.05
  加:期初现金及现金等价物余额4,006,435,846.794,006,435,846.794,131,859,602.144,131,859,602.14
  期末现金及现金等价物余额2,581,909,504.822,389,527,522.44,006,435,846.794,252,718,307.19
补充资料:
  净利润661,862,706.23-3,280,879,912.1-
  资产减值准备29,797,994.41-36,034,934.84-
  固定资产和投资性房地产折旧744,691,655.08-1,352,389,043.85-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧744,691,655.08-1,352,389,043.85-
  无形资产摊销25,891,648.42-49,442,167.88-
  长期待摊费用摊销22,078,508.3-41,023,855.2-
  处置固定资产、无形资产和其他长期资产的损失-10,663,776.45--834,727.21-
  固定资产报废损失6,456,826.23-37,764,435.04-
  公允价值变动损失-21,336,805.37--32,838,480.38-
  财务费用65,139,732.01-19,056,345.85-
  投资损失-57,912,082.18--57,847,648.05-
  递延所得税624,227--4,837,561.2-
  其中:递延所得税资产减少624,227-16,747,667.25-
    递延所得税负债增加---21,585,228.45-
  存货的减少-1,047,278,926.63-32,921,201.66-
  经营性应收项目的减少-216,263,282.68-291,262,779.09-
  经营性应付项目的增加180,347,214.46--197,284,586.92-
  其他---831,441,015.05-
  现金的期末余额2,581,909,504.82-4,006,435,846.79-
  减:现金的期初余额4,006,435,846.79-4,131,859,602.14-
  现金及现金等价物的净增加额-1,424,526,341.97--125,423,755.35-
公告日期2026-08-152026-04-222026-04-222025-10-30
审计意见(境内)标准无保留意见
TOP↑